Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary XKnife Radiosurgery Users Present New Spine and Lung Tumor Treatment Techniques
PLAINSBORO, N.J., Jul 27, 2007 (PrimeNewswire via COMTEX News Network) -- XKnife(TM) radiosurgery users presented their latest advances in the treatment of brain, spine and lung tumors on Sunday, July 22 at the 49th annual meeting of the American Association of Physicists in Medicine in
View HTML
Toggle Summary United States Supreme Court Vacates Circuit Court Decision in Integra LifeSciences -- Merck KGaA Litigation: Reasonableness Test Offered by Integra as Controlling Standard Remains Intact
United States Supreme Court Vacates Circuit Court Decision in Integra LifeSciences -- Merck KGaA Litigation: Reasonableness Test Offered by Integra as Controlling Standard Remains Intact PLAINSBORO, N.J., June 13, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today
View HTML
Toggle Summary Thomas Baltimore Steps Down as Director of Integra LifeSciences
PLAINSBORO, N.J., Aug. 27, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that Thomas J. Baltimore, Jr. has resigned from its Board of Directors to focus on his role as Chief Executive Officer of RLJ Lodging Trust (NYSE:RLJ) and to reduce his outside
View HTML
Toggle Summary SeaSpine to Join Integra LifeSciences at the 2015 UBS Global Healthcare Conference
PLAINSBORO, N.J., May 13, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Keith Valentine, Chief Executive Officer of SeaSpine, will join Integra to present at the 2015 UBS Global Healthcare Conference.
View HTML
Toggle Summary Richard Gorelick, Corporate Vice President and General Counsel of Integra LifeSciences, Named NJBIZ General Counsel of the Year Winner
PLAINSBORO, N.J., June 4, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Richard Gorelick, Corporate Vice President, General Counsel, Administration and Secretary, was named as 2015 NJBIZ General Counsel of the Year of public companies with
View HTML
Toggle Summary Richard E. Caruso, Chairman of the Board of Integra LifeSciences Holdings Corporation, Named Ernst & Young Entrepreneur of the Year 2006 National Winner
Richard E. Caruso, Chairman of the Board of Integra LifeSciences Holdings Corporation, Named Ernst & Young Entrepreneur of the Year 2006 National Winner PLAINSBORO, N.J., Nov. 20, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Richard E.
View HTML
Toggle Summary Richard E. Caruso, Chairman of the Board of Integra LifeSciences Holdings Corporation, Named Ernst & Young Entrepreneur Of The Year 2006 Award Winner in the Greater Philadelphia Region
Richard E. Caruso, Chairman of the Board of Integra LifeSciences Holdings Corporation, Named Ernst & Young Entrepreneur Of The Year 2006 Award Winner in the Greater Philadelphia Region PLAINSBORO, N.J., July 7, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced
View HTML
Toggle Summary Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge
Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge Plainsboro, New Jersey, July 15, 2002-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Absorbable Collagen Sponge
View HTML
Toggle Summary Radiosurgery Clinicians Present Latest Advances in Brain and Spine Tumor Treatments Using Integra LifeSciences Radionics XKnife System
PLAINSBORO, N.J., Aug 20, 2008 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Radionics(R) XKnife(R) clinicians presented their latest advances in the treatment of brain and spine tumors on Sunday, July 27th at the 50th annual
View HTML
Toggle Summary Press Release Providing Update Regarding Class I Recall of Shelhigh, Inc.'s EnDura
Integra LifeSciences Corporation ("Integra," d/b/a Integra NeuroSciences) is conducting a recall of all EnDura™ No-React® Dural Substitute ("EnDura") products. The EnDura products are manufactured by Shelhigh, Inc. ("Shelhigh") and distributed by Integra.
View HTML